.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Queensland Health
Express Scripts
Boehringer Ingelheim
Argus Health
Novartis
Cerilliant
Moodys
McKesson
Johnson and Johnson

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,037,845

« Back to Dashboard

Summary for Patent: 5,037,845

Title: Indole derivative
Abstract:A compound of formula (I) ##STR1## and its physiologically acceptable salts and solvates are described as useful in treating and/or preventing pain resulting from dilatation of the cranial vasculature in particular migraine. The compound (I) may be prepared, for example, by cyclizing a compound of formula (II) ##STR2##
Inventor(s): Oxford; Alexander W. (Royston, GB2)
Assignee: Glaxo Group Limited (GB2)
Application Number:07/317,682
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,037,845

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8419575Aug 01, 1984

International Patent Family for Patent: 5,037,845

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria386196► Subscribe
AustriaA226685► Subscribe
Australia4568985► Subscribe
Australia573878► Subscribe
Belgium903006► Subscribe
Canada1241004► Subscribe
Switzerland666026► Subscribe
Cyprus1475► Subscribe
Czech Republic280530► Subscribe
Czech Republic9104041► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Federal Trade Commission
Argus Health
AstraZeneca
Fuji
Fish and Richardson
Dow
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot